Release Date: 31/08/09 12:03 Summary: Preliminary Final Report Price Sensitive: Yes Download Document 864.68KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%